University of Vermont College of Medicine
1 South Prospect Street
Burlington, Vermont 05401
802-656-8990 http://www.med.uvm.edu/clinicaltrials clinicaltrials@uvm.edu

Use our guide to learn which trials are right for you!

The integrated academic health center at the University of Vermont College of Medicine and Fletcher Allen Health Care, its teaching hospital, has contributed to medical research for nearly two centuries. Recently, our academic health center has dramatically increased its clinical research productivity by using innovative methods of recruitment and state-of-the-art technology, evolving into one of the top research centers in the region. In order to meet the needs of our industry partners, our clinical research enterprise is structured with a focus on integrity, promptness, and flexibility, enhanced by the extensive resources of the institution, including the Vermont Children's Hospital, the General Clinical Research Center, the Vermont Cancer Center, the Vermont Lung Center, a dedicated Research Pharmacy, and many other research services. In addition, our outstanding relationship with private practices in the region strongly enhances the recruitment activities of clinical trials.

As one of the first medical schools founded in the United States, groundbreaking medical research has been a hallmark of the institution for decades. Among the many innovations developed here include a breakthrough new medicine for life-threatening sepsis pioneered by our researchers, and development of new treatments for depression in senior citizens. We are one of only 20 states in the nation to have both a National Institutes of Health-funded General Clinical Research Center, a National Cancer Institute funded Comprehensive Cancer Center. Our long history of excellence in research, teaching, and patient care, coupled with our dedication to attracting quality research projects, ensures that research conducted here will be efficient, effective and completed on time. We are an investigational site with nearly 200 years of clinical research experience in conducting Phase I - IV trials. In addition to study coordination, our staff can provide consulting in protocol development and design, manuscript preparation, and medical writing.

Some of our specialties include:

  • Addiction Research and Education
  • Asthma, Allergy and Immunology
  • Cardiology
  • Critical Care Medicine
  • Dermatology
  • Endocrinology, Diabetes and Metabolism
  • Emergency Medicine
  • Family Medicine
  • Food and Nutrition
  • Genetics
  • Gastroenterology and Hepatology
  • Geriatrics
  • Hematology
  • Infectious Diseases
  • Imaging Sciences
  • Medical Genetics
  • Medical Microbiology and Immunology
  • Medical Physics
  • Molecular and Cellular Pharmacology
  • Nephrology and Renal Disorders
  • Neurology and Neuroscience
  • Obstetrics and Gynecology
  • Oncology
  • Ophthalmology and Visual Science
  • Organ Transplantation
  • Orthopedics and Rehabilitation
  • Osteoporosis
  • Pathology
  • Pediatrics (all sub-specialties)
  • Pharmacology
  • Physiology
  • Preventive Medicine
  • Psychiatry
  • Pulmonary Medicine - Respiratory Care
  • Radiology
  • Rehabilitation Medicine
  • Rheumatology and Clinical Immunology
  • Sports Medicine
  • Surgery (all sub-specialties)
  • Tobacco Research and Intervention
  • Urology
  • Vascular Disease

Investigator and Staff:

A private, publicly supported integrated health care system, our organization features a medical staff of 700 physicians and a nursing staff of over 1,200 registered nurses. Our clinical research staff has coordinated hundreds of studies for pharmaceutical and biotechnology industry sponsors, foundations, and the National Institutes of Health. We deliver high-quality, accurate results by adhering closely to research protocols. Our experienced study coordinating, recruiting, and research staff is readily available to quickly address questions and to meet with monitors.

In this section of the site we invite you to learn more about the University of Vermont College of Medicine and Fletcher Allen Health Care - from our mission and history to our research departments and the communities we serve. Serving a population of more than one million in Vermont, northern New York, and throughout New England, we have an established network to provide us with rapid referrals of new patients so that we may quickly reach your enrollment goals.


Cardiology/Vascular Diseases
Dermatology/Plastic Surgery
Endocrinology
Gastroenterology
Hematology
Immunology/Infectious Diseases
Musculoskeletal
Nephrology/Urology
Neurology
Obstetrics/Gynecology
Oncology
Ophthalmology
Otolaryngology
Pediatrics/Neonatology
Pharmacology/Toxicology
Psychiatry/Psychology
Pulmonary/Respiratory Diseases
Rheumatology
Trauma/Emergency Medicine

The University of Vermont College of Medicine, in alliance with Fletcher Allen Health Care, is a premier academic medical center in the northeast and one of 125 in the country. Our mission is to improve the health in the communities we serve through compassionate patient care, education and research. The outstanding caregivers at Fletcher Allen - including nationally-renown physicians, specialized nurses and allied health professionals - are committed to providing our patients with only the highest-quality care. The academic medical center takes an active role in participating in finding cures to today's illnesses through medical research and training tomorrow's health professionals. The 562-bed includes more than 40 patient care sites and 100 outreach clinics.


Kimberly Luebbers, MSHS, RN, BSN, OCN ®
Director Office of Clinical Trials Research
University of Vermont College of Medicine
Office of Clinical Trials Research
UHC Campus, Arnold 3437
1 South Prospect Street
Burlington, VT 05401
USA
802-656-8990
802-656-4074 (fax)
clinicaltrials@uvm.edu
www.med.uvm.edu/clinicaltrials


We've found
69 trials
at this facility
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of Kidney Tumors in Younger Patients
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Breast Cancer Clinical Trial
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Previously Treated Non-Small Cell Lung Cancer Clinical Trial
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Clinical Trial
International Guillain-Barré Syndrome Outcome Study
Status: Enrolling
Updated: 1/4/2017
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Cediranib Maleate and Olaparib or Standard Chemotherapy in Treating Patients With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Lung Carcinoma Clinical Trial
Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Nonsmall Cell Lung Cancer Clinical Trial
Skeletal Muscle Atrophy and Dysfunction in Human Cancer
Status: Enrolling
Updated: 4/30/2018
mi
from
Burlington, VT
Click here to add this to my saved trials
Acute Respiratory Failure Clinical Trial
Novel Arm Restraint in the Intensive Care Unit
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Project: Every Child for Younger Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Women in Cardiac Rehabilitation: Optimizing the Training Response
Status: Enrolling
Updated: 2/13/2018
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 2/3/2016
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Skeletal Muscle Atrophy and Dysfunction Following Total Knee Arthroplasty
Status: Enrolling
Updated: 4/30/2018
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
PI3K/mTOR Inhibitor LY3023414 in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Acute Respiratory Failure Clinical Trial
Nutrition and Exercise in Critical Illness
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Transitional Rehabilitation in CABG Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Neuropsychological and Behavioral Testing in Younger Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB or Stage IIIB-IVB Hodgkin Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 4/9/2018
mi
from
Burlington, VT
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Alternative Exercise Program to Improve Skeletal Muscle Function and Fatigue in Cancer Survivors
Status: Enrolling, Phase I, II
Updated: 4/30/2018
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials
Anterior Cruciate Ligament Reconstruction Clinical Trial
Prevention of Skeletal Muscle Adaptations to Traumatic Knee Injury and Surgery
Status: Enrolling, Phase I, II
Updated: 4/30/2018
mi
from
Burlington, VT
Click here to add this to my saved trials
Malignant Neoplasm Clinical Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Burlington, VT
Click here to add this to my saved trials